Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer

Background/Aim: The study aimed to evaluate differences in the overall survival of HER2+ breast cancer patients treated with regard to their hormone receptors negativity or positivity. We evaluated a cohort of patients treated with trastuzumab in the Czech Republic. Patients and Methods: The present...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:In Vivo
Autors principals: KOLAROVA, IVETA, DUSEK, LADISLAV, RYSKA, ALES, ODRAZKA, KAREK, DOLEZEL, MARTIN, VANASEK, JAROSLAV, MELICHAR, BOHUSLAV, PETERA, JIRI, BUCHLER, TOMAS, VOSMIK, MILAN, PETRAKOVA, KATARINA, TERAROVA, PETRA, VILASOVA, ZDENA, JARKOVSKY, JIRI
Format: Artigo
Idioma:Inglês
Publicat: International Institute of Anticancer Research 2020
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7811660/
https://ncbi.nlm.nih.gov/pubmed/33144452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12183
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars